Lieberman FS - Search Results

1

Promise and pitfalls of quantitative imaging in oncology clinical trials.

Kurland BF, Gerstner ER, Mountz JM, Schwartz LH, Ryan CW, Graham MM, Buatti JM, Fennessy FM, Eikman EA, Kumar V, Forster KM, Wahl RL, Lieberman FS. Kurland BF, et al. Among authors: lieberman fs. Magn Reson Imaging. 2012 Nov;30(9):1301-12. doi: 10.1016/j.mri.2012.06.009. Epub 2012 Aug 13. Magn Reson Imaging. 2012. PMID: 22898682 Free PMC article. Review.

2

Activity of a first-in-class oral HIF2-alpha inhibitor, PT2385, in patients with first recurrence of glioblastoma.

Strowd R, Ellingson B, Raymond C, Yao J, Wen PY, Ahluwalia M, Piotrowski A, Desai A, Clarke JL, Lieberman FS, Desideri S, Nabors LB, Ye X, Grossman S. Strowd R, et al. Among authors: lieberman fs. J Neurooncol. 2023 Oct;165(1):101-112. doi: 10.1007/s11060-023-04456-7. Epub 2023 Oct 21. J Neurooncol. 2023. PMID: 37864646 Free PMC article. Clinical Trial.

3

A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM).

Kleinberg L, Ye X, Supko J, Stevens GHJ, Shu HK, Mikkelsen T, Lieberman F, Lesser GJ, Lee E, Grossman SA. Kleinberg L, et al. J Neurooncol. 2023 Dec;165(3):499-507. doi: 10.1007/s11060-023-04514-0. Epub 2023 Nov 28. J Neurooncol. 2023. PMID: 38015376 Clinical Trial.

4

Phase II study of border zone stereotactic radiosurgery with bevacizumab in patients with recurrent or progressive glioblastoma multiforme.

Mantica M, Drappatz J, Lieberman F, Hadjipanayis CG, Lunsford LD, Niranjan A. Mantica M, et al. J Neurooncol. 2023 Aug;164(1):179-190. doi: 10.1007/s11060-023-04398-0. Epub 2023 Jul 29. J Neurooncol. 2023. PMID: 37515669 Clinical Trial.

5

Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma.

Fanucci K, Pilat MJ, Shyr D, Shyr Y, Boerner S, Li J, Durecki D, Drappatz J, Puduvalli V, Lieberman FS, Gonzalez J, Giglio P, Ivy SP, Bindra RS, Omuro A, LoRusso P. Fanucci K, et al. Among authors: lieberman fs. Cancer Res Commun. 2023 Feb 2;3(2):192-201. doi: 10.1158/2767-9764.CRC-22-0436. eCollection 2023 Feb. Cancer Res Commun. 2023. PMID: 36968138 Free PMC article. Clinical Trial.

6

Comparison of proton magnetic resonance spectroscopy with fluorine-18 2-fluoro-deoxyglucose positron emission tomography for assessment of brain tumor progression.

Imani F, Boada FE, Lieberman FS, Davis DK, Deeb EL, Mountz JM. Imani F, et al. Among authors: lieberman fs. J Neuroimaging. 2012 Apr;22(2):184-90. doi: 10.1111/j.1552-6569.2010.00561.x. Epub 2010 Dec 14. J Neuroimaging. 2012. PMID: 21155917 Free PMC article.

7

Combined imaging biomarkers for therapy evaluation in glioblastoma multiforme: correlating sodium MRI and F-18 FLT PET on a voxel-wise basis.

Laymon CM, Oborski MJ, Lee VK, Davis DK, Wiener EC, Lieberman FS, Boada FE, Mountz JM. Laymon CM, et al. Among authors: lieberman fs. Magn Reson Imaging. 2012 Nov;30(9):1268-78. doi: 10.1016/j.mri.2012.05.011. Epub 2012 Jul 21. Magn Reson Imaging. 2012. PMID: 22819581 Free PMC article.

8

Distinguishing pseudoprogression from progression in high-grade gliomas: a brief review of current clinical practice and demonstration of the potential value of 18F-FDG PET.

Oborski MJ, Laymon CM, Lieberman FS, Mountz JM. Oborski MJ, et al. Among authors: lieberman fs. Clin Nucl Med. 2013 May;38(5):381-4. doi: 10.1097/RLU.0b013e318286c148. Clin Nucl Med. 2013. PMID: 23510887 Free PMC article.

9

Molecular and metabolic pattern classification for detection of brain glioma progression.

Imani F, Boada FE, Lieberman FS, Davis DK, Mountz JM. Imani F, et al. Among authors: lieberman fs. Eur J Radiol. 2014 Feb;83(2):e100-5. doi: 10.1016/j.ejrad.2013.06.033. Epub 2013 Nov 20. Eur J Radiol. 2014. PMID: 24321226 Free PMC article.

10

Assessment of early therapy response with 18F-FLT PET in glioblastoma multiforme.

Oborski MJ, Demirci E, Laymon CM, Lieberman FS, Mountz JM. Oborski MJ, et al. Among authors: lieberman fs. Clin Nucl Med. 2014 Oct;39(10):e431-2. doi: 10.1097/RLU.0000000000000321. Clin Nucl Med. 2014. PMID: 24368529

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

114 results

Search Page

Filters